Shubha Bhat

636 total citations
47 papers, 401 citations indexed

About

Shubha Bhat is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Shubha Bhat has authored 47 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 10 papers in Pediatrics, Perinatology and Child Health and 10 papers in Epidemiology. Recurrent topics in Shubha Bhat's work include Inflammatory Bowel Disease (14 papers), Pharmaceutical studies and practices (10 papers) and Biosimilars and Bioanalytical Methods (9 papers). Shubha Bhat is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Pharmaceutical studies and practices (10 papers) and Biosimilars and Bioanalytical Methods (9 papers). Shubha Bhat collaborates with scholars based in United States, India and Canada. Shubha Bhat's co-authors include Francis A. Farraye, John W. Devlin, Russel J. Roberts, Yoanna Skrobik, David Choi, James C. Lee, Taha Qazi, Stephanie A. Flowers, George T. Kondos and Mayank Kansal and has published in prestigious journals such as Gastroenterology, Critical Care Medicine and The American Journal of Gastroenterology.

In The Last Decade

Shubha Bhat

42 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shubha Bhat United States 12 89 76 70 69 56 47 401
Seçil Arıca Türkiye 12 22 0.2× 27 0.4× 18 0.3× 71 1.0× 11 0.2× 67 455
Erez Battat Israel 11 24 0.3× 8 0.1× 23 0.3× 169 2.4× 45 0.8× 24 736
Hasan Tolga Çelik Türkiye 12 12 0.1× 49 0.6× 21 0.3× 68 1.0× 16 0.3× 67 356
Shyh Poh Teo Brunei 8 10 0.1× 21 0.3× 38 0.5× 18 0.3× 9 0.2× 55 329
Jason J. Bischof United States 10 29 0.3× 53 0.7× 4 0.1× 44 0.6× 11 0.2× 57 422
Thida Ong United States 15 20 0.2× 21 0.3× 19 0.3× 118 1.7× 23 0.4× 37 690
Mitja Lääperi Finland 12 84 0.9× 8 0.1× 7 0.1× 79 1.1× 5 0.1× 47 443
Sarah Ziegler Switzerland 9 16 0.2× 73 1.0× 51 0.7× 89 1.3× 9 0.2× 11 622
Qin Sun China 13 4 0.0× 87 1.1× 38 0.5× 88 1.3× 16 0.3× 27 455
Shawkat Dhanani United States 13 19 0.2× 24 0.3× 66 0.9× 40 0.6× 4 0.1× 23 387

Countries citing papers authored by Shubha Bhat

Since Specialization
Citations

This map shows the geographic impact of Shubha Bhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shubha Bhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shubha Bhat more than expected).

Fields of papers citing papers by Shubha Bhat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shubha Bhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shubha Bhat. The network helps show where Shubha Bhat may publish in the future.

Co-authorship network of co-authors of Shubha Bhat

This figure shows the co-authorship network connecting the top 25 collaborators of Shubha Bhat. A scholar is included among the top collaborators of Shubha Bhat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shubha Bhat. Shubha Bhat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nadeem, Ahmed, et al.. (2024). Peri-Operative Optimization of Patients with Crohn’s Disease. Current Gastroenterology Reports. 26(5). 125–136. 1 indexed citations
2.
Cavallari, Larisa H., Jeannine S. McCune, Jennifer Trofe‐Clark, et al.. (2024). Decoding pharmacogenomic test interpretation and application to patient care. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(6). 581–588.
3.
Bhat, Shubha, et al.. (2024). Healthcare Access for Patients With Inflammatory Bowel Disease in the United States: A Survey by the Crohn’s & Colitis Foundation. Inflammatory Bowel Diseases. 31(7). 1819–1832. 1 indexed citations
4.
Bhat, Shubha, et al.. (2024). Biosimilars in IBD: What Every Clinician Needs to Know. Current Gastroenterology Reports. 26(3). 77–85. 5 indexed citations
5.
6.
McFarland, M. Shawn, Kayla R. Stover, Shubha Bhat, et al.. (2023). Charting a new path forward for pharmacy residency expansion. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(2). 205–212. 2 indexed citations
7.
Bhat, Shubha, Ruishen Lyu, Richard S. Bloomfeld, et al.. (2023). Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus. Inflammatory Bowel Diseases. 30(6). 950–959. 7 indexed citations
8.
Choi, David, et al.. (2022). Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn’s Disease. Annals of Pharmacotherapy. 57(5). 579–584. 11 indexed citations
9.
Kroehl, Miranda, Danielle F. Loeb, Shubha Bhat, et al.. (2021). An evaluation of clinical decision support tools for Patient Health Questionnaire-9 administration. Mental Health Clinician. 11(5). 267–273. 3 indexed citations
10.
Kim, Ji Yoon & Shubha Bhat. (2021). Safety of Rapid Infliximab Biosimilar Infusions in Patients With Inflammatory Bowel Disease. Annals of Pharmacotherapy. 56(3). 280–284. 3 indexed citations
11.
Bhat, Shubha, Jimmy K. Limdi, Raymond K. Cross, & Francis A. Farraye. (2021). Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease. Digestive Diseases and Sciences. 66(8). 2513–2532. 12 indexed citations
12.
Bhat, Shubha, Francis A. Farraye, Mary S. Hayney, & Freddy Caldera. (2021). How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients With Inflammatory Bowel Disease and Chronic Liver Disease. Gastroenterology. 164(7). 1047–1051. 6 indexed citations
13.
Choi, David, et al.. (2021). Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis. Annals of Pharmacotherapy. 56(5). 592–599. 22 indexed citations
14.
Bhat, Shubha, Catherine G. Derington, & Katy E. Trinkley. (2020). Clinicians' Values and Preferences for Medication Adherence and Cost Clinical Decision Support in Primary Care: A Qualitative Study. Applied Clinical Informatics. 11(3). 405–414. 10 indexed citations
15.
Bhat, Shubha & Taha Qazi. (2020). Switching from Infliximab to Biosimilar in Inflammatory Bowel Disease: A Review of Existing Literature and Best Practices. Crohn s & Colitis 360. 3(1). otaa093–otaa093. 10 indexed citations
16.
Bhat, Shubha, et al.. (2020). Additional clinical pharmacists roles during COVID‐19. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(4). 825–825. 7 indexed citations
17.
Fosnight, Sue, et al.. (2019). Prevalence and Predictors of Benzodiazepine Monotherapy in Patients With Depression. The Journal of Clinical Psychiatry. 80(4). 6 indexed citations
18.
Bhat, Shubha, Miranda Kroehl, Katy E. Trinkley, et al.. (2017). Evaluation of a Clinical Pharmacist-Led Multidisciplinary Antidepressant Telemonitoring Service in the Primary Care Setting. Population Health Management. 21(5). 366–372. 10 indexed citations
19.
Bhat, Shubha, et al.. (2014). Pharmacokinetic parameters of meloxicam after its oral administration in goat. Veterinary World. 7(3). 141–145. 5 indexed citations
20.
Roberts, Russel J., Robin Ruthazer, Amy Chi, et al.. (2011). Impact of a national propofol shortage on duration of mechanical ventilation at an academic medical center*. Critical Care Medicine. 40(2). 406–411. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seçil Arıca Breakdown of academic impact, for papers by Erez Battat Breakdown of academic impact, for papers by Hasan Tolga Çelik Breakdown of academic impact, for papers by Shyh Poh Teo Breakdown of academic impact, for papers by Jason J. Bischof Breakdown of academic impact, for papers by Thida Ong Breakdown of academic impact, for papers by Mitja Lääperi Breakdown of academic impact, for papers by Sarah Ziegler Breakdown of academic impact, for papers by Qin Sun Breakdown of academic impact, for papers by Shawkat Dhanani
Rankless by CCL
2026